05-062026
Structural Rewiring of IL-7R Dimerization by an Oncogenic Transmembrane Mutation Can Be Reversed by Rational Design
Mutations in transmembrane domains (TMDs) of cytokine receptors often drive ligand-independent signaling in cancer, yet their mechanisms remain unclear. Here, we show that an oncogenic mutation in the IL-7 receptor rewires its dimerization mode to enable constitutive activation. Structure-guided transmembrane peptides selectively disrupt this aberrant signaling, providing a strategy to target disease-causing TMD mutations.